Collaboration

Partnership across alliance

Pharma, Biotech, and academia are constantly shifting their business models, seeking to access external innovation and enhance the value in medicinal products. With the onset of the Covid-19 pandemic outdated R&D strategies are now being replaced more quickly by novel, more efficient approaches to global clinical trial conduct. With this article we share the benefit of being an ACROSS Global Alliance partner and how Clinichain fits in this unique model from a global equipment provision perspective.